(TXN) Texas Instruments - Ratings and Ratios
Analog, Digital, Microcontrollers, Semiconductors, Embedded
Dividends
| Dividend Yield | 3.01% |
| Yield on Cost 5y | 3.81% |
| Yield CAGR 5y | 9.05% |
| Payout Consistency | 94.8% |
| Payout Ratio | 98.9% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 31.4% |
| Value at Risk 5%th | 48.4% |
| Relative Tail Risk | -6.40% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.01 |
| Alpha | -22.58 |
| CAGR/Max DD | 0.14 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.738 |
| Beta | 1.300 |
| Beta Downside | 1.329 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.41% |
| Mean DD | 10.00% |
| Median DD | 8.57% |
Description: TXN Texas Instruments December 01, 2025
Texas Instruments (NASDAQ:TXN) designs, manufactures, and sells a broad portfolio of analog and embedded processing semiconductors to customers worldwide, spanning the United States, China, the rest of Asia, Europe, the Middle East, Africa, and Japan. The Analog segment supplies power-management components (e.g., DC-DC converters, linear regulators) and signal-chain products (e.g., amplifiers, data converters), while the Embedded Processing segment offers microcontrollers, processors, wireless/radar solutions, and DLP technology for applications ranging from industrial automation to automotive electronics.
Key data points to contextualize TXN’s positioning: • FY 2023 revenue reached $21.5 billion, with the Analog business contributing roughly 65 % of total sales, reflecting its resilience amid cyclical demand. • The company’s gross margin has consistently hovered around 60 %, driven by a high-mix, high-value product mix and strong pricing power. • Macro drivers such as the global shift to electric vehicles, AI-enabled edge computing, and the ongoing need for energy-efficient power-management are expanding the addressable market for TI’s analog and embedded solutions, while a relatively low exposure to the volatile consumer-electronics segment buffers earnings volatility.
For a deeper quantitative view of TXN’s valuation metrics and scenario analysis, you may find ValueRay’s research platform useful as a next step.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (5.04b TTM) > 0 and > 6% of Revenue (6% = 1.04b TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 1.79pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 62.31% (prev 77.56%; Δ -15.26pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.20 (>3.0%) and CFO 6.90b > Net Income 5.04b (YES >=105%, WARN >=100%) |
| Net Debt (10.73b) to EBITDA (8.11b) ratio: 1.32 <= 3.0 (WARN <= 3.5) |
| Current Ratio 4.45 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (914.0m) change vs 12m ago -0.65% (target <= -2.0% for YES) |
| Gross Margin 57.48% (prev 58.63%; Δ -1.14pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 49.10% (prev 44.48%; Δ 4.62pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 11.71 (EBITDA TTM 8.11b / Interest Expense TTM 532.0m) >= 6 (WARN >= 3) |
Altman Z'' 11.17
| (A) 0.31 = (Total Current Assets 13.88b - Total Current Liabilities 3.12b) / Total Assets 35.00b |
| (B) 1.50 = Retained Earnings (Balance) 52.37b / Total Assets 35.00b |
| warn (B) unusual magnitude: 1.50 — check mapping/units |
| (C) 0.18 = EBIT TTM 6.23b / Avg Total Assets 35.16b |
| (D) 2.94 = Book Value of Equity 53.96b / Total Liabilities 18.38b |
| Total Rating: 11.17 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 62.54
| 1. Piotroski 6.50pt |
| 2. FCF Yield 1.29% |
| 3. FCF Margin 12.05% |
| 4. Debt/Equity 0.84 |
| 5. Debt/Ebitda 1.32 |
| 6. ROIC - WACC (= 7.78)% |
| 7. RoE 30.41% |
| 8. Rev. Trend -59.05% |
| 9. EPS Trend -76.62% |
What is the price of TXN shares?
Over the past week, the price has changed by +8.48%, over one month by +11.60%, over three months by -2.00% and over the past year by -2.34%.
Is TXN a buy, sell or hold?
- Strong Buy: 10
- Buy: 2
- Hold: 21
- Sell: 2
- Strong Sell: 2
What are the forecasts/targets for the TXN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 189.6 | 3.8% |
| Analysts Target Price | 189.6 | 3.8% |
| ValueRay Target Price | 191.7 | 5% |
TXN Fundamental Data Overview November 29, 2025
P/E Trailing = 30.6503
P/E Forward = 24.3902
P/S = 8.8602
P/B = 9.036
P/EG = 1.4279
Beta = 0.994
Revenue TTM = 17.27b USD
EBIT TTM = 6.23b USD
EBITDA TTM = 8.11b USD
Long Term Debt = 13.55b USD (from longTermDebt, last quarter)
Short Term Debt = 500.0m USD (from shortTermDebt, last quarter)
Debt = 14.05b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.73b USD (from netDebt column, last quarter)
Enterprise Value = 161.84b USD (152.98b + Debt 14.05b - CCE 5.19b)
Interest Coverage Ratio = 11.71 (Ebit TTM 6.23b / Interest Expense TTM 532.0m)
FCF Yield = 1.29% (FCF TTM 2.08b / Enterprise Value 161.84b)
FCF Margin = 12.05% (FCF TTM 2.08b / Revenue TTM 17.27b)
Net Margin = 29.21% (Net Income TTM 5.04b / Revenue TTM 17.27b)
Gross Margin = 57.48% ((Revenue TTM 17.27b - Cost of Revenue TTM 7.34b) / Revenue TTM)
Gross Margin QoQ = 57.42% (prev 57.89%)
Tobins Q-Ratio = 4.62 (Enterprise Value 161.84b / Total Assets 35.00b)
Interest Expense / Debt = 1.00% (Interest Expense 141.0m / Debt 14.05b)
Taxrate = 13.89% (220.0m / 1.58b)
NOPAT = 5.36b (EBIT 6.23b * (1 - 13.89%))
Current Ratio = 4.45 (Total Current Assets 13.88b / Total Current Liabilities 3.12b)
Debt / Equity = 0.84 (Debt 14.05b / totalStockholderEquity, last quarter 16.63b)
Debt / EBITDA = 1.32 (Net Debt 10.73b / EBITDA 8.11b)
Debt / FCF = 5.16 (Net Debt 10.73b / FCF TTM 2.08b)
Total Stockholder Equity = 16.58b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.41% (Net Income 5.04b / Total Assets 35.00b)
RoE = 30.41% (Net Income TTM 5.04b / Total Stockholder Equity 16.58b)
RoCE = 20.67% (EBIT 6.23b / Capital Employed (Equity 16.58b + L.T.Debt 13.55b))
RoIC = 17.75% (NOPAT 5.36b / Invested Capital 30.22b)
WACC = 9.97% (E(152.98b)/V(167.03b) * Re(10.81%) + D(14.05b)/V(167.03b) * Rd(1.00%) * (1-Tc(0.14)))
Discount Rate = 10.81% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.05%
[DCF Debug] Terminal Value 64.74% ; FCFE base≈1.84b ; Y1≈1.51b ; Y5≈1.08b
Fair Price DCF = 14.54 (DCF Value 13.21b / Shares Outstanding 908.6m; 5y FCF grow -21.37% → 3.0% )
EPS Correlation: -76.62 | EPS CAGR: -9.99% | SUE: 1.17 | # QB: 1
Revenue Correlation: -59.05 | Revenue CAGR: -0.50% | SUE: 1.27 | # QB: 4
EPS next Quarter (2026-03-31): EPS=1.28 | Chg30d=+0.001 | Revisions Net=-24 | Analysts=28
EPS next Year (2026-12-31): EPS=6.16 | Chg30d=+0.003 | Revisions Net=-25 | Growth EPS=+12.4% | Growth Revenue=+8.1%
Additional Sources for TXN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle